Hyperkalemia: Difference between revisions

No edit summary
(Remove refs with incorrect PMIDs (verified against PubMed))
 
(164 intermediate revisions by 35 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Serum potassium >5.0 mEq/L (some define >5.5 mEq/L)
*'''Life-threatening when >6.5 mEq/L''' or with ECG changes
*Most common electrolyte disorder causing [[cardiac arrest]]
*Potassium homeostasis:
**98% intracellular (maintained by Na/K-ATPase)
**Renal excretion is primary mechanism of potassium regulation


===Causes===
*Decreased excretion (most common mechanism):
**[[Acute kidney injury]] / [[chronic kidney disease]]
**Medications: ACE inhibitors, ARBs, K-sparing diuretics (spironolactone, amiloride), NSAIDs, trimethoprim, heparin
**[[Adrenal insufficiency]] (hypoaldosteronism)
**Type 4 renal tubular acidosis
*Transcellular shift (K moves out of cells):
**Acidosis (metabolic acidosis shifts K extracellularly)
**Insulin deficiency / [[DKA]]
**Tissue destruction: [[rhabdomyolysis]], tumor lysis, hemolysis, burns
**Succinylcholine, beta-blockers, digitalis toxicity
**Hyperkalemic periodic paralysis
*Increased intake: excessive supplementation, salt substitutes (KCl)
*Pseudohyperkalemia: hemolyzed sample, prolonged tourniquet, thrombocytosis, leukocytosis
**Always repeat level if unexpected


High = >5.5meq/L
==Clinical Features==
*Often asymptomatic until severe
*Muscle weakness, fatigue, paresthesias
*Ascending paralysis (may mimic [[Guillain-Barre]])
*'''Cardiac dysrhythmias''' (most dangerous manifestation)
*Nausea, vomiting, diarrhea


High! = >6.5meq/L
===ECG Changes (Progressive)===
 
*Peaked T waves (earliest change, typically >5.5 mEq/L)<ref>Montague BT, et al. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008;3(2):324-330. PMID 18235147</ref>
*Prolonged PR interval
 
*Widened QRS
==Diagnosis==
*Loss of P waves
 
*Sine wave pattern (pre-arrest)
 
*Ventricular fibrillation / asystole
Always consider pseudohyperkalemia (e.g. from hemolysis)
*'''ECG changes do NOT reliably correlate with K level''' — some patients arrest without warning
 
=== ===
 
 
===ECG===
 
 
6.5 - peaked Ts, inc PR, dec QT
 
7.5 - QRS widening, P flattening
 
8 - sine wave, v-fib, heart block
 


==Differential Diagnosis==
==Differential Diagnosis==
 
*Pseudohyperkalemia (hemolyzed specimen)
 
*[[Acute kidney injury]] / [[chronic kidney disease]]
1. Redistribution
*[[DKA]]
 
*[[Rhabdomyolysis]]
*Acidosis drives potassium out of the cells (e.g. DKA)
 
2. Cellular breakdown
*Rhabdomyolysis
*Hemolysis
*Tumor lysis syndrome
*Tumor lysis syndrome
*Crush
*[[Adrenal insufficiency]]
 
*Medication effect
B. Increased total body potassium
 
    1. Inadequate excretion
 
      a. Renal caused (acute or chronic renal failure-must have GFR<10)
 
      b. Mineralocorticoid deficiency or Addison's disease
 
      c. Drug-induced (potassium sparing diuretics [e.g., spironolactone] and ACE-inhibitors)
 
    2. Excessive intake
 
      a. Diet, meds
 
      b. Blood transfusion
 
C. Pseudohyperkalemia
 
    1. Hemolysis of the specimen
 
    2. Prolonged period of tourniquets occlusion prior to blood draw
 
    3. Thrombocytosis/leukocytosis
 
D. Misc
 
    1.  Succs, dib, B-blockers
 
 
==Treatment==
 
 
1) Calcium gluconate 1 amp IV (if ECG changes/hypotension/or >7; can give mult times)
 
Can also give Ca Gluconate 1 amp (but dissociates more slowly and must give more volume)
 
*Caution in dig-toxic patients!*
 
2) Albuterol neb 2.5mg x 3
 
3) 10 U reg insulin IV with 1 amp D50W IV now, and 1 amp in 15 min
 
4) 1 amp NaBicarb IV (over 5 min)
 
5) Kayexalate 30g PO (may cause volume overload; +/- 50mL sorbitol)
 
    -or rectal 50g enema


*6) Consider dialyisis (& ?lasix 20-40mg IVP)
==Evaluation==
*'''Stat ECG''' (most urgent — look for peaked T's, widened QRS)
*BMP: potassium level, creatinine (renal function), glucose, bicarbonate
*Repeat K level if unexpected (rule out pseudohyperkalemia)
*VBG/ABG (acidosis evaluation)
*Digoxin level if on digoxin (hyperkalemia potentiates digitalis toxicity)
*Urinalysis (myoglobinuria if rhabdomyolysis)
*Consider: CK, uric acid, phosphorus (tumor lysis), cortisol (adrenal insufficiency)


==Management==
===Step 1: Cardiac Membrane Stabilization===
*Calcium (does NOT lower K; protects myocardium from arrhythmia):
**Calcium gluconate 10%: 10-20 mL IV over 2-3 minutes (preferred; less tissue necrosis if extravasates)
**Calcium chloride 10%: 5-10 mL IV (via central line preferred; 3x more elemental calcium)
**Onset: 1-3 minutes; duration 30-60 minutes; may repeat in 5-10 min if ECG unchanged
**'''Give immediately if ECG changes present or K >6.5'''
*Caution in [[digoxin toxicity]]: calcium may worsen toxicity → use cautiously or consider digibind first


==Source ==
===Step 2: Shift Potassium Intracellularly===
*Insulin + Glucose (most reliable):<ref>Mahoney BA, et al. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev. 2005;(2):CD003235. PMID 15846652</ref>
**Regular insulin 10 units IV + D50W 25g (50 mL) IV
**Onset: 15-30 min; duration 4-6 hours; lowers K by 0.5-1.2 mEq/L
**Monitor glucose q30min x 4h (hypoglycemia occurs in up to 20%)
**Give D50 before or simultaneously with insulin
*Albuterol (nebulized):
**10-20 mg nebulized (4-8x standard asthma dose)
**Onset: 15-30 min; lowers K by 0.5-1.5 mEq/L
**Additive with insulin; 40% of patients are non-responders
*Sodium bicarbonate:
**50-100 mEq IV over 5-10 minutes
**Minimal effect as monotherapy; useful in setting of severe metabolic acidosis
**'''Do NOT rely on bicarb alone''' to lower potassium


===Step 3: Remove Potassium from Body===
*Loop diuretics (furosemide 40-80 mg IV): if adequate renal function
*Sodium polystyrene sulfonate (Kayexalate) 15-30g PO:
**Delayed onset (hours); controversial efficacy; risk of bowel necrosis
**Not recommended as acute treatment
*Patiromer (Veltassa) or sodium zirconium cyclosilicate (Lokelma):
**Newer potassium binders; better tolerated than Kayexalate
**Lokelma 10g PO may lower K within 1 hour
*Hemodialysis (most effective method of K removal):
**Indicated for: refractory hyperkalemia, severe renal failure, K >7 despite medical therapy


7/2/09 Adapted from Tintinalli, Donaldson, Pani
===Cardiac Arrest from Hyperkalemia===
*Standard ACLS + calcium 10-20 mL IV push
*Insulin + glucose + bicarb + albuterol simultaneously
*Avoid succinylcholine for intubation
*Consider emergent dialysis


==Disposition==
*Admit if K >6.0, ECG changes, renal failure, or ongoing cause
*ICU if severe (>7.0), ECG changes, or refractory to treatment
*Continuous telemetry for all admitted patients
*Consider discharge if mild hyperkalemia (5.0-5.5), known chronic cause, normal ECG, correctable precipitant


==See Also==
*[[Hypokalemia]]
*[[Acute kidney injury]]
*[[Diabetic ketoacidosis]]
*[[Rhabdomyolysis]]
*[[Cardiac arrest]]
*[[Digoxin toxicity]]


==References==
*Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. ''N Engl J Med''. 2004;351(6):585-592. PMID 15295051
*Weisberg LS. Management of severe hyperkalemia. ''Crit Care Med''. 2008;36(12):3246-3251. PMID 18936701
*Montford JR, Linas S. How dangerous is hyperkalemia? ''J Am Soc Nephrol''. 2017;28(11):3155-3165. PMID 28778861
*Long B, et al. An emergency medicine approach to hyperkalemia. ''Am J Emerg Med''. 2018;36(5):918-921. PMID 29548654


[[Category:FEN]]
[[Category:Renal]]
[[Category:Critical Care]]

Latest revision as of 10:25, 22 March 2026

Background

  • Serum potassium >5.0 mEq/L (some define >5.5 mEq/L)
  • Life-threatening when >6.5 mEq/L or with ECG changes
  • Most common electrolyte disorder causing cardiac arrest
  • Potassium homeostasis:
    • 98% intracellular (maintained by Na/K-ATPase)
    • Renal excretion is primary mechanism of potassium regulation

Causes

  • Decreased excretion (most common mechanism):
  • Transcellular shift (K moves out of cells):
    • Acidosis (metabolic acidosis shifts K extracellularly)
    • Insulin deficiency / DKA
    • Tissue destruction: rhabdomyolysis, tumor lysis, hemolysis, burns
    • Succinylcholine, beta-blockers, digitalis toxicity
    • Hyperkalemic periodic paralysis
  • Increased intake: excessive supplementation, salt substitutes (KCl)
  • Pseudohyperkalemia: hemolyzed sample, prolonged tourniquet, thrombocytosis, leukocytosis
    • Always repeat level if unexpected

Clinical Features

  • Often asymptomatic until severe
  • Muscle weakness, fatigue, paresthesias
  • Ascending paralysis (may mimic Guillain-Barre)
  • Cardiac dysrhythmias (most dangerous manifestation)
  • Nausea, vomiting, diarrhea

ECG Changes (Progressive)

  • Peaked T waves (earliest change, typically >5.5 mEq/L)[1]
  • Prolonged PR interval
  • Widened QRS
  • Loss of P waves
  • Sine wave pattern (pre-arrest)
  • Ventricular fibrillation / asystole
  • ECG changes do NOT reliably correlate with K level — some patients arrest without warning

Differential Diagnosis

Evaluation

  • Stat ECG (most urgent — look for peaked T's, widened QRS)
  • BMP: potassium level, creatinine (renal function), glucose, bicarbonate
  • Repeat K level if unexpected (rule out pseudohyperkalemia)
  • VBG/ABG (acidosis evaluation)
  • Digoxin level if on digoxin (hyperkalemia potentiates digitalis toxicity)
  • Urinalysis (myoglobinuria if rhabdomyolysis)
  • Consider: CK, uric acid, phosphorus (tumor lysis), cortisol (adrenal insufficiency)

Management

Step 1: Cardiac Membrane Stabilization

  • Calcium (does NOT lower K; protects myocardium from arrhythmia):
    • Calcium gluconate 10%: 10-20 mL IV over 2-3 minutes (preferred; less tissue necrosis if extravasates)
    • Calcium chloride 10%: 5-10 mL IV (via central line preferred; 3x more elemental calcium)
    • Onset: 1-3 minutes; duration 30-60 minutes; may repeat in 5-10 min if ECG unchanged
    • Give immediately if ECG changes present or K >6.5
  • Caution in digoxin toxicity: calcium may worsen toxicity → use cautiously or consider digibind first

Step 2: Shift Potassium Intracellularly

  • Insulin + Glucose (most reliable):[2]
    • Regular insulin 10 units IV + D50W 25g (50 mL) IV
    • Onset: 15-30 min; duration 4-6 hours; lowers K by 0.5-1.2 mEq/L
    • Monitor glucose q30min x 4h (hypoglycemia occurs in up to 20%)
    • Give D50 before or simultaneously with insulin
  • Albuterol (nebulized):
    • 10-20 mg nebulized (4-8x standard asthma dose)
    • Onset: 15-30 min; lowers K by 0.5-1.5 mEq/L
    • Additive with insulin; 40% of patients are non-responders
  • Sodium bicarbonate:
    • 50-100 mEq IV over 5-10 minutes
    • Minimal effect as monotherapy; useful in setting of severe metabolic acidosis
    • Do NOT rely on bicarb alone to lower potassium

Step 3: Remove Potassium from Body

  • Loop diuretics (furosemide 40-80 mg IV): if adequate renal function
  • Sodium polystyrene sulfonate (Kayexalate) 15-30g PO:
    • Delayed onset (hours); controversial efficacy; risk of bowel necrosis
    • Not recommended as acute treatment
  • Patiromer (Veltassa) or sodium zirconium cyclosilicate (Lokelma):
    • Newer potassium binders; better tolerated than Kayexalate
    • Lokelma 10g PO may lower K within 1 hour
  • Hemodialysis (most effective method of K removal):
    • Indicated for: refractory hyperkalemia, severe renal failure, K >7 despite medical therapy

Cardiac Arrest from Hyperkalemia

  • Standard ACLS + calcium 10-20 mL IV push
  • Insulin + glucose + bicarb + albuterol simultaneously
  • Avoid succinylcholine for intubation
  • Consider emergent dialysis

Disposition

  • Admit if K >6.0, ECG changes, renal failure, or ongoing cause
  • ICU if severe (>7.0), ECG changes, or refractory to treatment
  • Continuous telemetry for all admitted patients
  • Consider discharge if mild hyperkalemia (5.0-5.5), known chronic cause, normal ECG, correctable precipitant

See Also

References

  • Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. PMID 15295051
  • Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008;36(12):3246-3251. PMID 18936701
  • Montford JR, Linas S. How dangerous is hyperkalemia? J Am Soc Nephrol. 2017;28(11):3155-3165. PMID 28778861
  • Long B, et al. An emergency medicine approach to hyperkalemia. Am J Emerg Med. 2018;36(5):918-921. PMID 29548654
  1. Montague BT, et al. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008;3(2):324-330. PMID 18235147
  2. Mahoney BA, et al. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev. 2005;(2):CD003235. PMID 15846652